03/07/2022
18:55:00
+44 (0) 203 8794 460
Free Membership
Login
Watchlist
Kurse
Charts
Trades
News
Fundamental
Toplisten
Alerts
Portfolio
Orderbuch
Forum
PLUS1
Krypto
Börse & Märkte
Devisen
Rohstoffe
Welt Märkte
Follow Feed
Treten Sie unserer Gemeinschaft von Investoren!
JETZT ANMELDEN
Startseite
Investieren
Aktien
USA
NYSE
Johnson and Johnson
(JNJ)
Finanzwerte
Börsenkurse
Charts
Orderbuch
Trades
News
Finanzwerte
Historisch
Johnson & Johnson (JNJ) Fundamentals
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States.
SHARE INFORMATION
Market Cap
US$ 467.100.134.228
Shares Outstanding
2.631.401.804
Float
2.629.203.316
Percent Float
99,92%
Short Interest
0,00
Short Percent Float
0,0%
Short Interest Ratio
0,00
Short Interest Date
-
Latest Fiscal Dividend Per Share
US$ 4,19
Latest Fiscal Revenue
US$ 93.775.000.000
Latest Fiscal EPS
US$ 7,81
Latest Fiscal Date
2021-12-31
DIVIDENDS
Dividend (3 Years)
US$ 4,92
Dividend (5 Years)
US$ 5,56
Ex Dividend Date
2022-05-23
Dividend Rate
US$ 4,52
Dividend Yield
2,55%
Payment Cash
Cash
HOLDERS
Institutions
5.658
Institutional Holdings Date
2022-05-31
Institutional Bought Previous 3 Months
104.561.439
Institutional Holdings Percent
141,1%
Institutional Sold Previous 3 Months
117.998.554
Insider Holdings Date
2022-05-31
Insider Bought Previous 3 Months
45.058
Insider Holdings Percent
0,2
Insider Sold Previous 3 Months
92.264
Insider Shares Owned
4.185.538
TRADING INFO
52 Week High
US$ 186,69
52 Week Low
US$ 155,72
52 Week High Change
US$ 10,51
21 Day Moving Average
US$ 175,35
21 Day Extended Moving Average
US$ 176,4034
50 Day Moving Average
US$ 177,2181
50 Day Extended Moving Average
US$ 176,4852
200 Day Moving Average
US$ 168,454
200 Day Extended Moving Average
US$ 172,0437
10 Day Average Volume
9.094.147
20 Day Average Volume
7.703.537
30 Day Average Volume
7.712.063
50 Day Average Volume
7.704.773
Alpha
0.002244
Beta
0.6598
Standard Deviation
0.049521
R2
0.398136
7 Day Price Change
US$ -2,15
7 Day Percent Change
-1,2%
21 Day Price Change
US$ 3,80
21 Day Percent Change
2,19%
30 Day Price Change
US$ -2,02
30 Day Percent Change
-1,13%
Month to Date Price Change
US$ -2,02
Month to Date Percent Change
-1,13%
Quarter to Date Price Change
US$ 1,41
Quarter to Date Percent Change
0,8%
180 Day Price Change
US$ 8,62
180 Day Percent Change
5,1%
200 Day Price Change
US$ 14,13
200 Day Percent Change
8,65%
Year to Date Price Change
US$ 8,62
Year to Date Percent Change
5,1%
Johnson & Johnson (JNJ) Key Ratios
PROFITABILITY
EBIT Margin
22,5%
EBITDA Margin
30,1%
Pre-Tax Profit Margin
18,6%
Profit Margin Count
18,94%
Gross Margin
68,0%
Profit Margin TOT
18,94%
INCOME STATEMENTS
Revenue
US$ 71.568.000.000
Revenue Per Share
US$ 27,1977
Revenue (3 Years)
US$ 0,00
Revenue (5 Years)
US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book
-100,20
Total Debt To Equity
0,40
Int Coverage
164,10
Current Ratio
1,40
Leverage Ratio
2,40
Quick Ratio
1,10
Long Term Debt To Capital
0,28
VALUATION MEASURES
PE Ratio
23,90
Enterprise Value
US$ 468.491.805.289
Price to Sales
6,5267
Price to Free Cash
71,10
PE High Last 5 Years
310,40
Price To Book
6,20
Price To Cash Flow
20,30
PE Low Last 5 Years
18,70
Price to Tangible Book
-100,20
MANAGEMENT EFFECTIVENESS
Receivables Turnover
1,90
Invoice Turnover
2,90
Assets Turnover
0,20
Return Assets
11,30
Return on Equity
28,22
Return on Capital
19,19
Johnson & Johnson (JNJ) Profile
PROFILE INFO
Issue Type
CS
SEC Type
EQS
Auditor
PricewaterhouseCoopers LLP
CEO
Joaquin Duato
Emplyoees
144300
Last Audit
UQ
CIK
0000200406
Industry
Drug Manufacturers
Sector
Healthcare
NAICS
Pharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address
One Johnson and Johnson Plaza
New Brunswick, NJ 8933
Website
https://www.jnj.com
Facsimile
-
Telephone
+1 732 524-0400
Email
-
Kürzlich von Ihnen besucht
NYSE
JNJ
Johnson an..
Register now
to watch these stocks streaming on the ADVFN Monitor.
Monitor lets you view up to 110 of your favourite stocks at once and is
completely free
to use.
Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende
Allgemeine Geschäftsbedingungen
Investitionen Warnung
Copyright © 1999 - 2022
Datenschutzrichtlinie
Zustimmungseinstellungen
ADVFN UK
Investors Hub
ADVFN Italy
ADVFN Australia
ADVFN Brazil
ADVFN Canada
ADVFN Germany
ADVFN Japan
ADVFN Mexico
ADVFN France
ADVFN US
P: V:de D:20220703 17:55:00
Login
Ihre Daten wurden nicht erkannt.
Bitte versuchen Sie es nochmal
Benutzername
Passwort
Passwort vergessen?
support@advfn.de
Haben Sie kein Konto?
Jetzt registrieren